MOGO moringa capsules are now a Salmonella outbreak story, not a wellness debate, because FDA's outbreak page tells consumers not to eat, sell, or serve MOGO-brand moringa powder capsules from lots 15525AA, expiring June 2027, and 00926AA, expiring January 2028. [1]

The count is concrete: 18 people in 14 states, seven hospitalizations, no deaths reported in the FDA outbreak investigation, and products sold online through Amazon, eBay, and mogomoringa.com. [1]

FDA also notes why this needs a separate label in the reader's head, saying this investigation is distinct from previous 2026 moringa powder outbreaks, while the company's recall notice names the same two lots, says no other MOGO products are included, and says retained samples tested negative even as the recall proceeds as a precaution. [1] [2]

That tension is why the bottle check beats the ideology, since natural-product defense and supplement fear both skip the useful noun, lot number, and a matching capsule bottle is not a discourse object but a return-or-discard object.

The outbreak sequence matters because repeated moringa notices can blur together, and FDA's distinction keeps consumers from assuming one earlier recall covers every later bottle or that every moringa product is implicated, so the safest claim while the investigation continues is narrow: these MOGO lots, these sellers, these illnesses, and no settled contamination source yet.

-- NORA WHITFIELD, Chicago